DGAP-News: CN Creative Advances Regulatory Initiatives for Its Nicadex(TM) and Intellicig(R) Harm Reduction/Smoking Cessation Products
CN Creative Ltd.
30.05.2012 11:30
—————————————————————————
UK Manufacturing Facility Receives –Pharmaceutical Grade– cGMP Designation
Plans for Clinical Trial of Nicadex Electronic Inhaler Nicotine Replacement
Therapy On TrackWill Leverage MHRA Marketing Submission to Advance European and
US Regulatory Strategy
MANCHESTER, United Kingdom, 2012-05-30 11:30 CEST (GLOBE NE
